Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Buttari

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Neurobiology of Disease|June 19, 2023
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patientsAnna Di Maio, Tommaso Nuzzo, Luana Gilio, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Plos Pathogens|April 18, 2013
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisDaniela F Angelini, Barbara Serafini, Eleonora Piras, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Therapeutic Advances in Neurological Disorders|December 21, 2020
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patientsMario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, et al.
Neuroepidemiology|March 5, 2018
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture AnalysisAlessio Farcomeni, Antonio Cortese, Eleonora Sgarlata, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Journal of Neurochemistry|September 21, 2021
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosisMario Stampanoni Bassi, Tommaso Nuzzo, Luana Gilio, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosisSilvia Rossi, Fabio Buttari, Valeria Studer, et al.
Neurobiology of Disease|June 19, 2023
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patientsAnna Di Maio, Tommaso Nuzzo, Luana Gilio, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Plos Pathogens|April 18, 2013
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisDaniela F Angelini, Barbara Serafini, Eleonora Piras, et al.
Journal of Neuroinflammation|April 16, 2018
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Girolama A Marfia, et al.
Therapeutic Advances in Neurological Disorders|December 21, 2020
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patientsMario Stampanoni Bassi, Jelena Drulovic, Tatjana Pekmezovic, et al.
Neuroepidemiology|March 5, 2018
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture AnalysisAlessio Farcomeni, Antonio Cortese, Eleonora Sgarlata, et al.
Frontiers in Aging Neuroscience|September 27, 2021
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple SclerosisMario Stampanoni Bassi, Luana Gilio, Ennio Iezzi, et al.
Journal of Neurochemistry|September 21, 2021
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosisMario Stampanoni Bassi, Tommaso Nuzzo, Luana Gilio, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Pageof 14